Simplex Trading
INO icon

Simplex Trading’s Inovio Pharmaceuticals INO Stock Holding History

Simplex Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199K Sell
114,300
-148,600
-57% -$245K ﹤0.01% 4306
2025
Q4 		$457K Sell
262,900
-134,200
-34% -$296K ﹤0.01% 3390
2025
Q3 		$929K Buy
397,100
+202,500
+104% +$388K ﹤0.01% 3130
2025
Q2 		$396K Buy
194,600
+175,800
+935% +$337K ﹤0.01% 3762
2025
Q1 		$30K Sell
18,800
-33,300
-64% -$66.8K ﹤0.01% 6245
2024
Q4 		$10K Buy
52,100
+1,400
+3% +$6.2K ﹤0.01% 7190
2024
Q3 		$293K Sell
50,700
-1,700
-3% -$14K ﹤0.01% 4158
2024
Q2 		$423K Sell
52,400
-6,100
-10% -$64.2K ﹤0.01% 3829
2024
Q1 		$811K Buy
58,500
+46,050
+370% +$398K ﹤0.01% 3343
2023
Q4 		$76K Sell
12,450
-592
-5% -$2.92K ﹤0.01% 5649
2023
Q3 		$60K Buy
13,042
+175
+1% +$967 ﹤0.01% 5638
2023
Q2 		$68K Buy
12,867
+84
+0.7% +$677 ﹤0.01% 5512
2023
Q1 		$125K Buy
12,783
+750
+6% +$12.8K ﹤0.01% 4906
2022
Q4 		$225K Buy
12,033
+1,925
+19% +$43.6K ﹤0.01% 4086
2022
Q3 		$209K Buy
10,108
+2,791
+38% +$71.5K ﹤0.01% 4549
2022
Q2 		$151K Buy
7,317
+442
+6% +$12.5K ﹤0.01% 4996
2022
Q1 		$296K Sell
6,875
-19,033
-73% -$857K ﹤0.01% 4576
2021
Q4 		$1.55M Sell
25,908
-300
-1% -$24K ﹤0.01% 2321
2021
Q3 		$2.98M Sell
26,208
-25
-0.1% -$2.51K ﹤0.01% 1680
2021
Q2 		$2.92M Buy
+26,233
New +$2.52M ﹤0.01% 1706
2021
Q1 		– Sell
-366
Closed -$3.88M – 9350
2020
Q4 		$3.88M Sell
366
-529
-59% -$70.4K 0.01% 1179
2020
Q3 		$12.5M Buy
895
+304
+51% +$63.4K 0.02% 444
2020
Q2 		$19.1M Buy
591
+198
+50% +$31.8K 0.03% 316
2020
Q1 		$3.51M Buy
393
+383
+3,830% +$23.6K 0.01% 897
2019
Q4 		$37K Buy
10
+8
+400% +$241 ﹤0.01% 5468
2019
Q3 		$4K Sell
2
-4
-67% -$122 ﹤0.01% 6694
2019
Q2 		$19K Buy
6
+2
+50% +$79 ﹤0.01% 5638
2019
Q1 		$15K Sell
4
-17
-81% -$857 ﹤0.01% 5890
2018
Q4 		$102K Buy
21
+11
+110% +$668 ﹤0.01% 3843
2018
Q3 		$64K Buy
10
+5
+100% +$278 ﹤0.01% 4910
2018
Q2 		$21K Buy
5
+2
+67% +$110 ﹤0.01% 5821
2018
Q1 		$3K Sell
3
-1
-25% -$54 ﹤0.01% 4992
2017
Q4 		$6K Sell
4
-22
-85% -$1.36K ﹤0.01% 4334
2017
Q3 		$22K Sell
26
-9
-26% -$670 ﹤0.01% 3060
2017
Q2 		$27K Buy
35
+30
+600% +$2.57K ﹤0.01% 2989
2017
Q1 		$1K Sell
5
-34
-87% -$2.71K ﹤0.01% 5671
2016
Q4 		$12K Sell
39
-22
-36% -$1.99K ﹤0.01% 3560
2016
Q3 		$105K Sell
61
-21
-26% -$2.32K 0.01% 1493
2016
Q2 		$143K Buy
82
+44
+116% +$5.34K 0.01% 1223
2016
Q1 		$94K Buy
38
+14
+58% +$1.08K 0.01% 1407
2015
Q4 		$13K Buy
24
+11
+85% +$876 ﹤0.01% 3077
2015
Q3 		$15K Sell
13
-2
-13% -$174 ﹤0.01% 3074
2015
Q2 		$12K Buy
15
+8
+114% +$855 ﹤0.01% 2908
2015
Q1 		$19K Sell
7
-1
-13% -$97 ﹤0.01% 2373
2014
Q4 		$21K Buy
+8
New +$978 ﹤0.01% 2009

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's INO Position: Q2 2025 in Review

Simplex Trading sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 8,176 shares — an estimated $15.7K sold.

Simplex Trading first reported a position in INO in Q1 2015 and held it in 33 quarters. The position peaked at $497K in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.

  • Simplex Trading reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 8,176 Inovio Pharmaceuticals shares in Q2 2025, an estimated $15.7K.
  • Simplex Trading first reported a position in Inovio Pharmaceuticals in Q1 2015 and held it in 33 quarters.
  • Simplex Trading's Inovio Pharmaceuticals position peaked at $497K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.